Dark History Podcast Summary: Episode 157 - "The Painkiller Problem: How Fentanyl Took Over America"

Host: Bailey Sarian
Release Date: January 22, 2025
Podcast: Dark History by Audioboom Studios

Bailey Sarian, renowned for her engaging storytelling in the true crime genre, dives deep into the complex and tragic history of fentanyl in Episode 157 of Dark History. This episode meticulously traces fentanyl’s journey from a groundbreaking medical breakthrough to one of America’s most devastating public health crises.

1. Introduction to Fentanyl

Bailey opens the episode by sharing a personal anecdote about her experience with fentanyl post-surgery, highlighting the drug's dual-edged nature. She expresses her confusion and concern over fentanyl’s sudden surge in popularity outside medical settings.

Bailey (00:00): "How did the fentanyl epidemic become a problem too big to stop? Well, let's find out."

2. The Origins of Fentanyl

Bailey traces fentanyl’s origins to Paul Jansen, a Belgian scientist whose tragic loss of his sister to tuberculosis fueled his passion for pain management. Her narrative emphasizes Jansen’s relentless pursuit to create a more effective painkiller.

• Paul Jansen's Contribution:
  Jansen founded Janssen Pharmaceutica and focused on developing stronger pain relief medications. By 1960, his team successfully synthesized fentanyl, making it 50 times stronger than meperidine and 25 times more potent than morphine.

3. Medical Approval and Early Use

Johnson & Johnson’s acquisition of Janssen Pharmaceutica played a pivotal role in fentanyl’s widespread medical adoption. Despite initial resistance from Dr. Robert Dripps, a professor of anesthesiology who warned against fentanyl’s addictive potential, the FDA approved fentanyl in 1968 in highly diluted doses to mitigate addiction risks.

Bailey (09:07): "Dr. Drips assumed the FDA would be true to their word. So in 1968, fentanyl is approved by the FDA, but only in a very specific 50 to 1 dose."

4. Expanding the Market

By the late 1970s and early 1980s, fentanyl became a staple in surgical procedures worldwide. The expiration of its patent in 1981 led to its mass production by various pharmaceutical companies, resulting in diverse forms such as patches, nasal sprays, and even lollipops aimed at pediatric use.

Bailey (14:39): "In 1984, a fentanyl lollipop called Oralette was introduced. It was made for kids and adults before surgery."

5. Transition to Illicit Use

The shift from medical to illicit use began in the early 2000s as fentanyl started appearing on the black market. Its potency made it a lucrative filler for other drugs like heroin, MDMA, and cocaine, often unbeknownst to users, leading to a dramatic increase in overdose fatalities.

Bailey (22:58): "These pills and powders then get sold under the name of other, you know, drugs that people are using, like MDMA and cocaine."

6. The Overdose Crisis Unfolds

Bailey details the alarming rise in fentanyl-related deaths, spotlighting high-profile cases such as the overdose of musician Prince in 2016 and rapper Mac Miller in 2018. She underscores the devastating statistics, revealing that from 1999 to 2021, nearly 645,000 people died from overdoses involving opioids, including fentanyl.

Bailey (31:04): "Nearly 645,000 people have died from overdoses, including any opioid, prescription, and illicit fentanyl from 1999 to 2021."

7. Efforts to Combat the Epidemic

The episode discusses governmental and societal responses to the fentanyl crisis. Initiatives such as fentanyl testing strips and the widespread availability of Narcan (a medication that can reverse opioid overdoses) are highlighted as critical measures in reducing fatalities. Additionally, international efforts, particularly by China, to restrict precursor chemicals used in fentanyl production, are examined.

Bailey (37:34): "Narcan is a life-saving drug. If someone is having an overdose, an opioid overdose, this Narcan will restore normal breathing."

8. Societal Impact and Personal Reflections

Bailey reflects on the broader societal implications of the fentanyl crisis, emphasizing addiction as a treatable mental disorder rather than a moral failing. She advocates for compassion, support, and accessible treatment options for those struggling with substance use disorders.

Bailey (43:19): "Addiction is a mental illness. It's defined as a treatable mental disorder. You just need proper help and support around you."

9. Conclusion and Future Directions

In concluding the episode, Bailey acknowledges the multifaceted nature of the fentanyl epidemic, attributing it to factors such as pharmaceutical practices, regulatory oversights, and societal issues exacerbated by events like the COVID-19 pandemic. She hints at ongoing struggles and the necessity for continued vigilance and innovation in combating drug abuse.

Bailey (41:39): "A lot of people are quick to point the finger at, you know, the people using the drugs, specifically the addicts. Like, whenever you bring up, like, oh, the heroin was laced with fentanyl, people are like, well, they shouldn't have been."

Key Takeaways:

• Fentanyl’s Potency: Originally developed as a potent medical painkiller, fentanyl’s strength made it both revolutionary and dangerous.
• Regulatory Challenges: Initial FDA measures to control fentanyl’s use were insufficient in preventing its misuse and addiction.
• Illicit Market Dynamics: The ease of producing and distributing fentanyl illicitly contributed significantly to the surge in overdose deaths.
• Public Health Response: Efforts like fentanyl testing strips and Narcan distribution are vital but need broader implementation and support.
• Stigma and Support: Recognizing addiction as a mental health issue is crucial for effective treatment and societal support systems.

Bailey Sarian’s exploration of fentanyl’s dark history in this episode of Dark History serves as a poignant reminder of the delicate balance between medical innovation and societal safety. Her thorough analysis provides listeners with a comprehensive understanding of how fentanyl evolved into a national crisis and underscores the importance of informed, compassionate responses to addiction.

Note: All timestamps correspond to the original podcast transcript provided.